{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:04:57Z","timestamp":1786460697106,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The aim of this systematic review will be to evaluate the effectiveness of palliative care for treating adults with end-stage liver disease (ESLD), focusing on outcomes such as quality of life, quality of care, symptom burden, and patient satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>ESLD is a critical health issue, characterized by various devitalizing symptoms that negatively affect quality of life for patients. Palliative care, which is a specialty used to alleviate pain and control other manifestations of the disease, has been suggested across various studies for the management of quality of life and symptom burden in patients with ESLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria:<\/jats:title>\n                    <jats:p>This review will include studies focusing on the use of palliative care for adults (\u226518 years) with ESLD. Papers that compare palliative care with usual care or placebo will also be included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The review will follow the JBI methodology for systematic reviews of effectiveness. PubMed, Embase (Ovid), Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL (EBSCOhost), Scopus, and Web of Science will be searched for published studies. Sources to be searched for unpublished literature will include Google Scholar, ProQuest Dissertations and Theses Global, Shodhganga, MedNar, OpenGrey, and the WHO International Clinical Trials Registry Platform. Two independent reviewers will assess titles, abstracts, and full-text papers against the inclusion criteria. A third reviewer will resolve any discrepancies. Standardized JBI appraisal tools will be used to critically appraise eligible studies. Two independent reviewers will extract data. Meta-analysis will be conducted for outcomes, where feasible. If a meta-analysis cannot be conducted, the findings will be reported in a narrative format, adhering to the Synthesis Without Meta-analysis guidelines. Certainty of evidence will be reported using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review registration:<\/jats:title>\n                    <jats:p>PROSPERO CRD42024586855<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-24-00454","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:00:39Z","timestamp":1750060839000},"page":"2104-2112","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of palliative care for the management of end-stage liver disease: a systematic review protocol"],"prefix":"10.11124","volume":"23","author":[{"given":"Harshitha","family":"Manjunath","sequence":"first","affiliation":[{"name":"Department of Allied Health Sciences, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Manoj","sequence":"additional","affiliation":[{"name":"Department of Allied Health Sciences, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1739-580X","authenticated-orcid":false,"given":"Bhagya","family":"S","sequence":"additional","affiliation":[{"name":"Department of Allied Health Sciences, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Rani S","sequence":"additional","affiliation":[{"name":"Anaesthesia and Operation Theatre Technology, Department of Allied Health Sciences, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chithra","family":"Venkateswaran","sequence":"additional","affiliation":[{"name":"Founder, Mehac Foundation, Kochi, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-632X","authenticated-orcid":false,"given":"Denny","family":"John","sequence":"additional","affiliation":[{"name":"Public Health, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India"},{"name":"Evidence Synthesis and Implementation for Indigenous Health: A JBI Affiliated Group, Manbhum Ananda Ashram Nityananda Trust (MANT), Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"1","key":"R1-20251011","doi-asserted-by":"crossref","first-page":"e13893","DOI":"10.1111\/hex.13893","article-title":"The experiences of people with liver disease of palliative and end-of-life care in the United Kingdom: a systematic literature review and meta-synthesis","volume":"27","author":"Beresford","year":"2024","journal-title":"Health Expect"},{"issue":"1","key":"R2-20251011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis","volume":"33","author":"Peng","year":"2019","journal-title":"Palliat Med"},{"key":"R4-20251011","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20251011","doi-asserted-by":"crossref","first-page":"A264","DOI":"10.1136\/gutjnl-2015-309861.568","article-title":"PWE-119: a complex symptom burden and unmet need in end-stage liver disease","volume":"64","author":"Kriese","year":"2015","journal-title":"Gut"},{"issue":"6","key":"R6-20251011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000507336","article-title":"Palliative care in end-stage liver disease patients awaiting liver transplantation: review","volume":"27","author":"Vieira Silva","year":"2020","journal-title":"GE Port J Gastroenterol"},{"issue":"7","key":"R7-20251011","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/S2214-109X(19)30172-X","article-title":"The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions","volume":"7","author":"Sleeman","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"6","key":"R8-20251011","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/jpm.2024.0111","article-title":"When is the optimal time to refer patients with end-stage liver disease to palliative care specialists?","volume":"27","author":"Ghoshal","year":"2024","journal-title":"J Palliat Med"},{"issue":"5","key":"R9-20251011","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clinthera.2022.04.012","article-title":"4th. Nutrition as therapy in liver disease","volume":"44","author":"Shah","year":"2022","journal-title":"Clin Ther"},{"issue":"2","key":"R10-20251011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/SGA.0000000000000611","article-title":"How do we start palliative care for patients with end-stage liver disease?","volume":"45","author":"Kim","year":"2022","journal-title":"Gastroenterol Nurs"},{"issue":"7","key":"R11-20251011","doi-asserted-by":"crossref","first-page":"102416","DOI":"10.1016\/j.clinre.2024.102416","article-title":"Palliative care and end stage liver disease: a survey study comparing perspectives of hepatology and palliative care physicians and clinical scenarios that could require palliative care intervention","volume":"48","author":"Oliveira","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"R12-20251011","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jpainsymman.2020.04.027","article-title":"Redefining palliative care\u2014a new consensus-based definition","volume":"60","author":"Radbruch","year":"2020","journal-title":"J Pain Sympt Manag"},{"issue":"2","key":"R13-20251011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jceh.2022.08.003","article-title":"Palliative care for patients with end-stage liver disease","volume":"13","author":"Philips","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"R14-20251011","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/2047-3095.12423","article-title":"Psychosocial interventions aimed at family members caring for patients with cancer in the palliative period: a systematic review","volume":"35","author":"Y\u0131ld\u0131z","year":"2024","journal-title":"Int J Nurs Knowl"},{"issue":"12","key":"R15-20251011","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.cgh.2019.03.022","article-title":"Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease","volume":"17","author":"Ufere","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"R16-20251011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/flgastro-2019-101180","article-title":"Palliative care in liver disease: what does good look like?","volume":"11","author":"Woodland","year":"2019","journal-title":"Frontline Gastroenterol"},{"issue":"6","key":"R17-20251011","first-page":"e13708","article-title":"Assessment of patient symptom burden and information needs helps tailoring palliative care consultations: an observational study","volume":"31","author":"Verhoef","year":"2022","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"3","key":"R18-20251011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0973-1075.105683","article-title":"Palliative care in India: current progress and future needs","volume":"18","author":"Khosla","year":"2012","journal-title":"Indian J Palliat Care"},{"issue":"12","key":"R19-20251011","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1007\/s10620-020-06779-1","article-title":"Palliative care for patients with end-stage liver disease on the liver transplant waiting list: an international systematic review","volume":"66","author":"Vijeratnam","year":"2021","journal-title":"Dig Dis Sci"},{"key":"R20-20251011","article-title":"What do we know about patients\u2019 perspectives and expectations relating to palliative and end-of-life care in advanced liver disease? A systematic review of qualitative literature using ENTREQ guidelines","author":"Das","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"R22-20251011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"R23-20251011","doi-asserted-by":"crossref","first-page":"e0138237","DOI":"10.1371\/journal.pone.0138237","article-title":"The role of Google Scholar in evidence reviews and its applicability to grey literature searching","volume":"10","author":"Haddaway","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"R24-20251011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/XEB.0000000000000152","article-title":"Development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"},{"issue":"3","key":"R25-20251011","doi-asserted-by":"crossref","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"3","key":"R26-20251011","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid Synth"},{"issue":"3","key":"R27-20251011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.11124\/JBIES-24-00103","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies","volume":"23","author":"Barker","year":"2025","journal-title":"JBI Evid Synth"},{"key":"R28-20251011","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies","author":"Barker","year":"2025","journal-title":"JBI Evid Synth"},{"issue":"3","key":"R29-20251011","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"R31-20251011","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","author":"Campbell","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"R33-20251011","first-page":"82","article-title":"A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation","volume":"24","author":"Meader","year":"2024","journal-title":"Syst Rev"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-24-00454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:01:57Z","timestamp":1786453317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-24-00454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-24-00454","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}